Evidence for Apical Endocytosis in Polarized Hepatic Cells:  Phosphoinositide 3-Kinase Inhibitors Lead to the Lysosomal Accumulation  of Resident Apical Plasma Membrane Proteins by Tuma, Pamela L. et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/99/05/1089/14 $2.00
The Journal of Cell Biology, Volume 145, Number 5, May 31, 1999 1089Ð1102
http://www.jcb.org 1089
 
Evidence for Apical Endocytosis in Polarized Hepatic Cells: 
Phosphoinositide 3-Kinase Inhibitors Lead to the Lysosomal Accumulation 
of Resident Apical Plasma Membrane Proteins
 
Pamela L. Tuma, Catherine M. Finnegan, Ji-Hyun Yi, and Ann L. Hubbard
 
Department of Cell Biology and Anatomy, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
 
Abstract. 
 
The architectural complexity of the hepato-
cyte canalicular surface has prevented examination of 
apical membrane dynamics with methods used for 
other epithelial cells. By adopting a pharmacological 
approach, we have documented for the ﬁrst time the in-
ternalization of membrane proteins from the hepatic 
apical surface. Treatment of hepatocytes or WIF-B cells 
with phosphoinositide 3-kinase inhibitors, wortmannin 
or LY294002, led to accumulation of the apical plasma 
membrane proteins, 5
 
9
 
-nucleotidase and aminopepti-
dase N in lysosomal vacuoles. By monitoring the traf-
ﬁcking of antibody-labeled molecules, we determined 
that the apical proteins in vacuoles came from the api-
cal plasma membrane. Neither newly synthesized nor
transcytosing apical proteins accumulated in vacuoles. 
In wortmannin-treated cells, transcytosing apical pro-
teins traversed the subapical compartment (SAC),
suggesting that this intermediate in the basolateral-to-
apical transcytotic pathway remained functional. Ultra-
structural analysis conﬁrmed these results. However, 
apically internalized proteins did not travel through 
SAC en route to lysosomal vacuoles, indicating that 
SAC is not an intermediate in the apical endocytic 
pathway. Basolateral membrane protein distributions 
did not change in treated cells, uncovering another dif-
ference in endocytosis from the two domains. Similar 
effects were observed in polarized MDCK cells, sug-
gesting conserved patterns of phosphoinositide
3-kinase regulation among epithelial cells. These results 
conﬁrm a long-held but unproven assumption that lyso-
somes are the ﬁnal destination of apical membrane pro-
teins in hepatocytes. Signiﬁcantly, they also conﬁrm our 
hypothesis that SAC is not an apical endosome.
Key words: polarity • phosphoinositide 3-kinase • 
hepatocyte • endocytosis • subapical compartment
 
T
 
HE
 
 plasma membrane of polarized epithelial cells is
separated into discrete domains (apical and basolat-
eral) that are characterized by distinct activities and
protein compositions. The mechanisms that regulate the
polarized expression of proteins at a given cell surface are
currently actively being examined. We are investigating
the cellular itineraries of resident apical plasma membrane
proteins in hepatocytes. Our recent studies have been per-
formed in the polarized hepatic cell line, WIF-B (Ihrke et al.,
1993, 1998; Shanks et al., 1994). As observed in situ, WIF-B
apical membrane proteins that have been studied to date
are transported to the apical surface via an “indirect”
route (Bartles et al., 1987; Schell et al., 1992; Bartles and
Hubbard, 1988; Ihrke et al., 1998). The proteins are first
transported from the trans-Golgi network to the basolat-
eral plasma membrane, where they are retrieved by en-
docytosis and transcytosed to the apical cell surface. The
transcytosing molecules traverse through similar interme-
diate compartments (early endosomes and the subapical
compartment [SAC]
 
1
 
) in WIF-B cells as they do in situ
(Barr and Hubbard, 1993; Barr et al., 1995; Ihrke et al.,
1998). Many factors have been identified both in hepato-
cytes and WIF-B cells that are likely mediating transport
along both the biosynthetic and transcytotic pathways.
This “molecular machinery” includes the now familiar sol-
uble 
 
N
 
-ethylmaleimide–sensitive factor attachment pro-
tein receptor (SNARE) complex proteins, rab GTPases,
coat proteins and coat-nucleating factors, microtubules
and associated motors, and annexins (for review, see Ihrke
and Hubbard, 1995). Although the precise mechanisms by
which these molecules exert their physiological activities
are currently unknown, the framework is clearly set to di-
rect future investigations.
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Once hepatic apical plasma membrane proteins have
reached their specific destination (the bile canalicular/api-
cal plasma membrane), much less is known about the
mechanisms that retain them or regulate their turnover. A
major obstacle to our understanding of bile canalicular
events is the ultrastructural complexity of the liver. The
bile canaliculus is unique in its organization in the cell and
within the intact organ. Unlike the lumenal domains of
kidney or intestinal epithelia, the hepatocyte lumenal sur-
faces are branching networks between adjacent cells that
are not easily accessible to experimental manipulation. Al-
though WIF-B cells have emerged as an excellent in vitro
polarized hepatic cell model, the bile canalicular domain is
also sequestered from the external milieu and is not ame-
nable for the types of experimentation performed in sim-
pler, columnar epithelia.
Although structural constraints have hindered our abil-
ity to examine the dynamics of apical plasma membrane
proteins, theoretically we know that apical membrane re-
trieval systems must exist. Only in recent years has the ex-
tent of vesicle delivery to the apical domain been appreci-
ated. From studies of fluid phase transcytosis, it has been
estimated that 600–850 transcytotic vesicles (100 nm in di-
ameter) fuse with the apical surface every minute (Craw-
ford, 1996). This means that the apical membrane surface
area would double or triple every 20 min if not compen-
sated (Crawford, 1996). Early models proposed that the
detergent-like bile was responsible for the solubilization of
both membrane lipids and proteins from the canalicular
surface (for review, see Oude Elferink et al., 1995). By ex-
tension, this would help maintain the apical membrane
steady state surface area. However, we reported that a
maximum of only 20–30% of the loss of resident apical
proteins can be accounted for by passive solubilization
(Scott and Hubbard, 1992). Furthermore, recent work in
transgenic animals deficient in the multidrug resistance 2
(mdr2) P-glycoprotein gene has also challenged the solubi-
lization/release hypothesis (Smit et al., 1993; Groen et al.,
1995; Crawford et al., 1997).
We further infer the presence of apical membrane re-
trieval mechanisms from studies examining the proteins
present at that domain. For example, the polymeric IgA
receptor is continuously and robustly synthesized and de-
livered to the apical domain by transcytosis in hepatocytes.
Once delivered, the receptor is cleaved, releasing the
secretory component into the bile and leaving a 30-kD tail
fragment anchored in the membrane. Only a small propor-
tion of the tail has been detected in bile (Solari et al.,
1989), suggesting that other mechanisms are in place to rid
the apical domain of the fragment.
The most obvious mechanism in eukaryotic cells for the
retrieval and turnover of membrane proteins is endocyto-
sis and delivery to lysosomes. This degradative organelle is
clearly the destination of exogenous macromolecules en-
docytosed from the basolateral surface and of autophago-
cytosed bits of the hepatic cytoplasm. However, its role in
the turnover of plasma membrane proteins from the apical
surface has never been demonstrated, due primarily to the
long half-lives of apical membrane proteins and the atten-
dant difficulty in accumulating detectable levels before
their degradation.
Although examination of hepatic apical membrane dy-
namics has been difficult, there are strategies available.
 
One such strategy is to identify and localize molecules im-
plicated in membrane traffic. For example, the presence of
clathrin-coated profiles at the canalicular surface (Hub-
bard, A.L., unpublished observations) indicates that en-
docytic retrieval occurs at that domain and provides clues
to possible mechanisms. Additionally, soluble 
 
N
 
-ethylma-
leimide–sensitive factor attachment protein receptor mol-
ecules (Fujita et al., 1998), rab GTPases, and annexins (for
review, see Ihrke and Hubbard, 1995) have all been found
at the apical domain in hepatocytes. The functional studies
are needed to determine whether such molecules are regu-
lating transport events to or from the apical surface.
Another strategy includes examining the effects of vari-
ous pharmacological agents on canalicular membrane re-
trieval. For these studies, the preferred reagents should be
specific and effective disrupters of endocytic transport
steps. Both wortmannin and LY294002 fulfill these crite-
ria. Wortmannin is a potent irreversible inhibitor (IC
 
50
 
, 3 nM)
of all mammalian phosphoinositide 3-kinases (PI 3-kinases)
tested to date and, at nanomolar concentrations, its effect
is thought to be specific (Ui et al., 1995). LY294002, a re-
versible inhibitor, is also thought to be specific in its inhibi-
tion, but at higher (micromolar) concentrations (Vlahos et
al., 1993). In mammalian cells, many endocytic transport
steps have been shown to be sensitive to these agents, in-
cluding transferrin receptor internalization and recycling
(Li et al., 1995; Martys et al., 1996; Spiro et al., 1996),
horseradish peroxidase and albumin uptake (Li et al.,
1995; Brunskill et al., 1998), activated PDGF receptor
transport from the cell surface to lysosomes (Joly et al.,
1995), early endosome fusion (Jones and Clague, 1995),
autophagic vacuole formation (Blommart et al., 1997), and
basolateral-to-apical transcytosis of dimeric IgA, ricin,
and horseradish peroxidase (Cardone and Mostov, 1995;
Hansen et al., 1995; Folli et al., 1997).
Here we report that PI 3-kinase is also an important and
selective regulator of apical plasma membrane protein dy-
namics in hepatic cells. In the presence of wortmannin or
LY294002, a subset of resident apical plasma membrane
proteins accumulated in intracellular lysosomal vacuoles
in both liver hepatocytes and WIF-B cells. This is the first
documentation of membrane protein internalization from
the apical cell surface in hepatic cells. SAC, an intermedi-
ate of the basolateral-to-apical transcytotic pathway, re-
mained intact in treated cells, but was not an intermediate
of the apical endocytic pathway. The distributions of baso-
lateral membrane proteins did not change in the presence
of either inhibitor, indicating PI 3-kinases selectively regu-
late apical membrane proteins. The finding that MDCK
cells responded similarly to treatment with the inhibitors
suggests a general role for PI 3-kinase in apical membrane
transport in polarized cells. These results not only reveal
aspects of membrane protein dynamics previously not ob-
served, but also highlight the functional diversity of the
polarized cell surface.
 
Materials and Methods
 
Materials and Antibodies
 
Male Sprague-Dawley rats (125–150 g) were supplied by Charles River
Breeding Laboratories. Wortmannin, cycloheximide, cytochalasin D, and
nocodazole were purchased from Sigma Chemical Co. Wortmannin, cy- 
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tochalasin D, and nocodazole were stored at 
 
2
 
20
 
8
 
C as 10-, 1-, or 16.5-mM
stock solutions, respectively, in DMSO. Cycloheximide was prepared as a
10-mg/ml stock solution in 5% ethanol and used directly. LY294002 was
purchased from Calbiochem Corp. and stored at 
 
2
 
20
 
8
 
C as a 10-mM solu-
tion in DMSO. Cell culture media and FBS were purchased from GIBCO
BRL. Fluorescently labeled secondary antibodies were obtained from
Jackson ImmunoResearch Laboratories. Anti–
 
b
 
-tubulin antibodies were
obtained from Sigma Chemical Co. Texas red–conjugated phalloidin was
purchased from Molecular Probes Inc., and stored at 
 
2
 
20
 
8
 
C as a 200-U/ml
stock in methanol. The antibodies recognizing the 120-kD lysosomal
glycoprotein (LGP-120), mannose 6-phosphate receptor (M6P-R), 5
 
9
 
nucleo-
tidase (5
 
9
 
NT), and endogenous canine plasma membrane antigens (3F2
and G12) were kindly provided by W. Dunn (University of Florida,
Gainesville, FL), Peter Nissley (National Institutes of Health, Bethesda,
MD), Paul Luzio (Cambridge University, Cambridge, UK), and George
Ojakian (State University of New York, Oswego, New York), respec-
tively. Antibodies against aminopeptidase N (APN), CE9, HA4, asialogly-
coprotein receptor (ASGP-R), HA321, syntaxin 3, and endolyn-78 were
all prepared by the Hubbard laboratory and have been described else-
where (Bartles et al., 1985; Scott and Hubbard, 1992; Barr and Hubbard,
1993; Ihrke et al., 1993).
 
Cell Culture
 
WIF-B cells were grown in a humidified 7% CO
 
2
 
 incubator at 37
 
8
 
C as de-
scribed (Shanks et al., 1994). In brief, cells were grown in modified Ham’s
F12 medium, pH 7.0, supplemented with HAT (10 
 
m
 
M hypoxanthine,
40 nM aminoterpin, 1.6 
 
m
 
M thymidine) and 5% FBS. MDCK cells were
grown at 37
 
8
 
C in a 5% CO
 
2
 
 humidified incubator as described (Weisz et
al., 1992). For indirect immunofluorescence experiments, cells were
seeded onto glass coverslips at 1.3 
 
3
 
 10
 
4
 
 cells/cm
 
2
 
 and cultured for 8–12 d
(WIF-B) or 4–5 d (MDCK) until they reached maximal density and polar-
ity (Shanks et al., 1994).
 
Immunofluorescence Microscopy
 
To examine the effects of wortmannin or LY294002 on the steady state
distributions of various proteins, cells were incubated at 37
 
8
 
C up to 3 h in
their respective serum-free culture medium buffered with either 20 mM
Hepes, pH 7.0 (for WIF-B cells), or 44 mM NaHCO
 
3
 
,
 
 
 
pH 7.0 (for MDCK
cells), in the presence or absence of either agent (see Results or figure leg-
ends for details). After treatment, cells were rinsed briefly in PBS and
placed on ice, fixed with chilled PBS containing 4% paraformaldehyde for
1 min, and permeabilized with methanol (also chilled) for 10 min (Ihrke et
al., 1993). Cells were rehydrated in PBS by three washes of 5 min each.
Cells were further processed for single- or double-labeled indirect immu-
nofluorescence according to previously published methods (Ihrke et al.,
1993) with the following primary antibodies: anti–HA321, –LGP-120 and
–APN (rabbit polyclonals, 1:100, 1:200, and 1:300, respectively), anti–
5
 
9
 
NT, –endolyn and –HA4 (mouse monoclonal ascites, 1:300, 1:500, and
1:100, respectively). MDCK cells were processed for indirect immunofluo-
rescence using anti–3F2 and –G12 (hybridoma culture supernatants, 1:10).
The secondary antibodies (FITC or Cy3 goat anti–rabbit or anti–mouse)
were used at 5–10 
 
m
 
g/ml.
To assess the effects of microtubule, actin, or protein synthesis disrup-
tion on redistribution, cells were pretreated for 1 h at 37
 
8
 
C with nocoda-
zole (33 
 
m
 
M), cytochalasin D (1 
 
m
 
M), or cycloheximide (25 
 
m
 
g/ml), re-
spectively. Cells were incubated an additional 3 h at 37
 
8
 
C in the presence
of wortmannin, and the continued presence of either nocodazole, cytocha-
lasin D, or cycloheximide. The treatments were stopped by fixation and
the cells were processed for indirect immunofluorescence. Anti–
 
b
 
-tubulin
antibodies (mouse monoclonal) were diluted to 1:500. Texas red–conju-
gated phalloidin was diluted to 5 U/ml.
 
Isolated Liver Perfusion
 
Livers from fasted (12–18 h) rats (125–200 g) were surgically removed and
perfused in a recirculating balanced salt solution as described (Dunn et al.,
1983) in the absence or presence of 2 
 
m
 
M wortmannin and 50 
 
m
 
M leupep-
tin. Biopsies (0.25–1.0 g) were removed at the indicated times and fixed by
immersion in Krebs buffer containing 4% PFA for at least 1 h at room
temperature. The intact liver was fixed by perfusion with 200–300 ml of
the same fixative. After fixation, the biopsies and intact liver were pro-
cessed as described (Dunn et al., 1983) and semithin sections (0.5 
 
m
 
m) cut
with a Reichert Jung Ultracut E microtome. The liver sections were
processed for immunofluorescence according to previously published
methods (Hubbard et al., 1985) using the following primary antibodies:
anti–APN, –HA321 (rabbit polyclonals, 1:300 and 1:100, respectively),
anti–HA4 and –endolyn (mouse monoclonal ascites, 1:100 and 1:300, re-
spectively). The secondary antibodies (FITC or Cy3 goat anti–rabbit or
anti–mouse) were used at 5–10 
 
m
 
g/ml.
 
Transcytosis Assay
 
The transcytosis assays were performed as described (Ihrke et al., 1998).
WIF-B cells were placed in Hepes-buffered, serum-free medium and
treated at 37
 
8
 
C with the agents as specified in Results or the figure leg-
ends. The cells were placed on ice for 5 min to cool to 4
 
8
 
C. Antigens
present at the basolateral cell surface were labeled (those also present at
the apical plasma membrane are excluded from labeling) at 4
 
8
 
C for 15 min
with anti–APN (rabbit polyclonal, 1:50) or purified mouse monoclonal an-
tibodies against 5
 
9
 
NT (purified IgG fraction, 20–50 
 
m
 
g/ml) or CE9 (mouse
monoclonal ascites, 1:25). Total IgG was recovered from mouse ascites us-
ing EZ Sep (Pharmacia LKB Biotechnology Inc.) according to the instruc-
tions from the manufacturer. All antibodies were diluted in buffered, se-
rum-free medium containing 2 mg/ml BSA in the absence or presence of
the various agents. After labeling, the cells were washed extensively in
buffered, serum-free medium containing 2 mg/ml BSA to get rid of excess
and nonspecifically associated antibodies. Cells were then returned to
37
 
8
 
C and incubated for the desired times of chase in the absence or pres-
ence of the different agents (see Results or figure legends). Treatments
were stopped by fixation and permeabilization as described above. The
trafficked antibodies were labeled with Cy3- or FITC-conjugated goat
anti–rabbit or anti–mouse secondary antibodies (5–10 
 
m
 
g/ml) and visual-
ized by indirect immunofluorescence.
 
Electron Microscopy
 
The transcytosis assay was performed as described above with anti–5
 
9
 
NT
antibodies (20–50 
 
m
 
g/ml) directly conjugated to 5-nM gold particles (Slot
and Slot, 1985). The cells were fixed and processed in situ (on the glass
coverslip) using standard Epon embedding techniques (Ihrke et al., 1998).
Ultrathin sections were cut parallel to the growth substrate, stained with
lead citrate, visualized, and photographed with an EM10 transmission
electron microscope (Carl Zeiss, Inc.).
 
Imaging
 
The cells and perfused liver sections were visualized by epifluorescence
(Axioplan Universal Microscope; Carl Zeiss, Inc.). Pictures were taken
and processed using standard photographic techniques. Scanned images of
the photographic prints were compiled, and figures prepared using Adobe
Photoshop and Microsoft PowerPoint software. For Fig. 4, WIF-B immu-
nofluorescence was analyzed using a laser scanning confocal microscope
(LSCM 410; Carl Zeiss, Inc.). 
 
Results
 
PI 3-Kinase Inhibitors Alter the Steady State 
Distributions of Apical Plasma Membrane Proteins in 
WIF-B Cells
 
Our initial approach to examine the effects of the selective
inhibitors, wortmannin and LY294002, on apical plasma
membrane dynamics was to determine the steady state dis-
tributions of apical membrane proteins in WIF-B cells in
treated cells. As observed for other cell types, these agents
led to extensive vacuolation (compare Fig. 1 a with c, e,
and g). By indirect immunofluorescence, we observed that
the apical membrane proteins, 5
 
9
 
NT and APN, accumu-
lated in vacuoles after treatment with 100 nM wortmannin
or 200 
 
m
 
M LY294002 (compare Fig. 1 b with d, f, and h).
Similar patterns of redistribution were observed for dipep-
tidyl peptidase IV, another apical membrane protein (data
not shown). Vacuole size in cells treated with LY294002
was consistently smaller than observed in wortmannin-
treated cells for all markers examined. This may reflect
differences in the inhibitory mechanisms of these agents or 
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the decreased potency of LY294002 (Vlahos et al., 1993;
Ui et al., 1995).
Vacuole formation and accumulation of the apical pro-
teins into vacuoles were both time dependent, with vacu-
ole formation preceding redistribution (Fig. 2, a and b). By
phase microscopy, vacuoles were observed within 15 min
of treatment and, by 45 min, all cells contained numerous,
large vacuoles (Fig. 2, a and b). In contrast, apical proteins
were first faintly detected in vacuoles after 45 min of treat-
ment and did not reach their peak redistribution until after
120–180 min, when all cells were positive for vacuole stain-
ing (Fig. 2, a and b). The vacuoles containing apical pro-
teins increased in diameter as wortmannin treatment was
prolonged. At 45 min, apical protein-positive vacuoles
were 
 
z
 
1.9 
 
6 
 
0.5 
 
m
 
m in diameter, whereas by 180 min, the
diameter had increased to an average of 3.1 
 
6 
 
0.9 
 
m
 
m (Ta-
ble I). Both the increase in vacuole size and gradual accu-
mulation of apical protein staining suggest the inhibitors
allowed forward traffic into vacuoles, but blocked trans-
port from them. Alternatively, the inhibitors may have al-
tered the relative kinetics of membrane traffic to and from
the vacuole.
The wortmannin concentration used in this and many
other published studies was 100 nM. At higher concentra-
tions, wortmannin can inhibit other enzymes, including
myosin light chain kinase and PI 4-kinase (Ui et al., 1995).
To determine whether the effects described here were due
to specific inhibition of PI 3-kinase isoforms, we incubated
WIF-B cells with varying concentrations of wortmannin.
The extents and rates of accumulation of the apical pro-
teins and vacuole formation were similar in cells treated
with wortmannin concentrations ranging from 10 nM to
Figure 1. Apical plasma mem-
brane proteins accumulate in
vacuoles in the presence of
wortmannin (wtm) or LY-
294002. WIF-B cells were incu-
bated for 180 min in the absence
(a and b) or presence (c, d, g,
and h) of 100 nM wortmannin or
200  mM LY294002 (e and f).
Cells were fixed, permeabilized
and stained for APN (b, d, and
f) or 59NT (h). Arrows point to
vacuoles containing intracellular
apical proteins. Fluorescent im-
ages were intentionally overex-
posed so that vacuolar staining
was more visible. The control
staining in b was overexposed to
the same extent as treated cells.
59NT staining in control cells is
indistinguishable from that of
APN shown in a. Bar, 10 mm. 
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6 
 
m
 
M (data not shown). Also, increased times of treatment
with either agent (up to 10 h) did not lead to visibly
greater extents of accumulation (see Discussion).
Not all apical membrane proteins accumulated in vacu-
oles. Although the cells were heavily vacuolated after 180
min of treatment, both HA4 (Fig. 3 a) and syntaxin 3 (data
not shown) maintained their apical distributions. This sug-
gests that wortmannin and LY294002 were selectively per-
turbing protein trafficking rather than generally disrupting
apical membrane integrity. Interestingly, the distributions
of the resident basolateral plasma membrane proteins
HA321 (Fig. 3 b) and CE9 (data not shown) did not
change in the presence of either inhibitor, indicating the
effect was specific to proteins at the apical surface. In addi-
tion, the staining patterns of the tight junction component,
 
ZO-1, were not changed in the presence of wortmannin
(data not shown), suggesting tight junctions remained
intact during treatment. Together, these data indicate
that plasma membrane polarity was not compromised in
treated cells.
 
Identification of the Vacuoles as Lysosomal
 
We next determined what other molecules were present in
the vacuoles containing apical proteins. The distributions
of TGN-38, p115, and albumin (a major hepatic secretory
protein) were unaltered by wortmannin treatment (data
not shown). This is in agreement with findings from other
cell types that wortmannin does not affect organelles or
transport steps of the biosynthetic pathway (Brown et al.,
1995; Hansen et al., 1995; Martys et al., 1996; Reaves et al.,
1996; Shpetner et al., 1996). However, disruption of en-
docytic compartments has been reported in nonpolarized
cells. In particular, the formation of large intracellular vac-
uoles derived from early and late endosomes and lyso-
somes has been observed (Brown et al., 1995; Reaves et
al., 1996; Shepherd et al., 1996; Shpetner et al., 1996;
Spiro et al., 1996; Fernandez-Borja et al., 1999). We exam-
ined whether wortmannin induced similar morphological
changes in WIF-B cells. For these experiments, cells were
treated for 180 min with 100 nM wortmannin and the
steady state distributions of three recycling membrane
proteins, ASGP-R (an early endosomal membrane pro-
tein), M6P-R (a late endosomal membrane protein) and
endolyn-78 (a lysosomal membrane protein), were exam-
ined by confocal microscopy. The most notable vacuola-
tion was observed when cells were stained for endolyn-78
(Fig. 4, a, c, and e) or LGP-120 (data not shown). Unlike
reports from other cell types, few vacuoles contained early
or late endosomal markers (here, ASGP-R or M6P-R; Fig.
Figure 2. Vacuole formation precedes appearance of apical membrane proteins in vacuoles. WIF-B cells were treated for the indicated
times with 100 nM wortmannin, fixed, permeabilized, and double labeled for APN and endolyn (a) or 59NT and LGP-120 (b). Random
phase and fluorescent images were collected for each time point. From phase images, the number of cells containing vacuoles was
counted. Vacuoles were defined as the large, spherical intracellular structures induced by wortmannin treatment. From fluorescent im-
ages, cells containing vacuoles that stained positive for resident apical membrane (APN or 59NT) or resident lysosomal membrane pro-
teins (endolyn or LGP-120) were counted. The plotted values are averages from three experiments 6 SD.
 
Table I. The Diameter of Vacuoles that Contain Resident 
Apical Plasma Membrane Proteins Increases with Prolonged 
Wortmannin Treatment
 
Time Vacuole size
 
min
 
m
 
m
 
0 0.0 
 
6
 
 0.0
15 0.0 
 
6
 
 0.0
45 1.9 
 
6
 
 0.5
90 2.2 
 
6
 
 0.6
120 2.7 
 
6
 
 0.8
180 3.1 
 
6
 
 0.9
 
WIF-B cells were treated with 100 nM wortmannin for the indicated times at 37°C.
The cells were fixed, permeabilized, and processed for indirect immunofluorescent
detection of APN or 5
 
9
 
NT. The diameters of vacuoles containing the apical proteins
were measured. For each time point, fluorescent images were digitally captured
(350
 
3
 
 magnification) from 8–10 random fields and vacuoles counted. In general, two
to three vacuoles per cell were measured and, for each time point, 104 vacuoles were
analyzed. Only polarized cells were included in the analysis. Approximate numbers of
vacuoles per cell remained the same during wortmannin treatment. Values are ex-
pressed as the mean 
 
6
 
 SD. Measurements were performed on three experiments. 
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4, d and f). Rather, these markers were primarily found in
intracellular structures that did not significantly overlap
with the endolyn-78 positive structures. These results indi-
cate that wortmannin was disrupting mainly lysosomal
compartments in WIF-B cells.
Comparison of APN and endolyn-78 staining patterns
revealed striking colocalization (Fig. 4, a and b). After 180
min of wortmannin treatment, all cells contained vacuoles
that were positive for both APN and endolyn-78 (Fig. 4, a
and b). Similar results were obtained when 5
 
9
 
NT distribu-
tions were compared with those of another resident lyso-
somal membrane protein, LGP-120 (data not shown). The
kinetics of appearance of endolyn or LGP-120 into vacu-
oles generally paralleled those of vacuole formation itself
and preceded the appearance of apical plasma membrane
proteins (Fig. 2, a and b). By 45 min, the majority of cells
examined contained vacuoles that were positive for en-
dolyn-78 and LGP-120 and, by 120 min, redistribution was
complete. The appearance of LGP-120 in vacuoles consis-
tently trailed the appearance of endolyn-78. Whether this
reflects differences in their cellular itineraries or kinetics
(Ihrke et al., 1998) is not known. From these data, we con-
clude that the apical plasma membrane proteins accumu-
lated in lysosomally derived vacuoles in the presence of PI
3-kinase inhibitors.
 
The Apical Plasma Membrane Proteins Observed in 
Vacuoles Originate from the Apical Cell Surface
 
The apical proteins found in vacuoles could have origi-
nated from three possible sources: from the biosynthetic
pathway, the transcytotic pathway, or from the apical
plasma membrane itself. To rule out a biosynthetic origin,
WIF-B cells were pretreated in the absence or presence of
25 
 
m
 
g/ml cycloheximide for 60 min to inhibit protein syn-
thesis. Cells were further incubated for 180 min with 100 nM
wortmannin in the continued absence or presence of cy-
cloheximide. Cells treated with wortmannin alone or with
cycloheximide and wortmannin achieved the same levels
of vacuole formation (100% positive cells) and 5
 
9
 
NT vacu-
ole redistribution (92 and 93% positive cells, respectively).
Cells treated with cycloheximide alone were not observed
Figure 3. Plasma membrane po-
larity is maintained in the pres-
ence of wortmannin. WIF-B
cells were treated for 180 min
with 100 nM wortmannin. The
cells were fixed, permeabilized,
and processed for indirect im-
munofluorescence. HA4 stain-
ing (a) was detected at the apical
membrane with no intracellular
vacuolar staining and HA321
staining (b) detected only at the
basolateral. Phase images of
these cells were indistinguish-
able from those shown in Fig. 1,
d, f, and h. *Bile canalicular
space in b. Overexposure of im-
ages as in Fig. 1 revealed no vac-
uolar staining. Bar, 10 mm.
Figure 4. The apical plasma
membrane proteins accumulate
in vacuoles that also contain res-
ident lysosomal membrane pro-
teins. Cells were treated for 180
min with 100 nM wortmannin,
fixed, permeabilized, and pro-
cessed for indirect immunofluo-
rescence. Confocal images of
cells double labeled for endolyn
(a) and APN (b), endolyn (c)
and ASGP-R (d), or endolyn (e)
and M6P-R (f) are shown. *Bile
canaliculi. Arrows are pointing
to vacuoles that contain ASGP-R
(d) or M6P-R (f). The APN
image was overexposed to
enhance vacuolar visibility. Bar,
10 mm. 
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to vacuolate, nor did apical plasma membrane protein dis-
tributions change. Similar results were obtained for APN,
further indicating that newly synthesized apical proteins
were not the source of apical molecules accumulating in
vacuoles.
We next investigated the possibility that the apical
membrane proteins observed in vacuoles originated from
the transcytotic pathway. For these experiments, WIF-B
cells were pretreated in the absence or presence of 100 nM
wortmannin for 15 min at 37
 
8
 
C. Transcytosis of apical pro-
teins was examined after their labeling with specific anti-
bodies at 4
 
8
 
C. Since the antibodies were excluded from the
apical plasma membrane by tight junctions, only those
molecules en route from the basolateral plasma mem-
brane were labeled (Ihrke et al., 1998; and see Fig. 5, a and
d). After extensive washing, the cells were warmed to 37
 
8
 
C
and the antibody–antigen complexes chased for the indi-
cated times. The cells were fixed and permeabilized and
the trafficked antibody–antigen complexes were visualized
with secondary antibodies.
After 90 min in control cells, the majority of 5
 
9
 
NT stain-
ing was observed at or near the apical plasma membrane
and, after 180 min, nearly all transcytosing 5
 
9
 
NT was at the
apical surface signaling its successful delivery (Fig. 5, a–c,
and see the ultrastructural analysis, g and h). Similarly, in
wortmannin-treated cells, 5
 
9
 
NT was also successfully de-
livered to the apical plasma membrane by 180 min. How-
ever, we observed more intracellular accumulation of the
trafficked molecule after 90 min (Fig. 5 e). Similar results
were obtained for APN and HA4 in both control and
wortmannin- or LY294002-treated cells (data not shown).
We also monitored the dynamics of the resident basolat-
eral protein, CE9, using the antibody-labeling and traf-
ficking approach. In wortmannin-treated cells, CE9
maintained its basolateral distributions (data not shown),
further indicating that PI 3-kinases differentially regulate
resident proteins at each domain.
Because only a 15-min wortmannin pretreatment was
used in these experiments, we needed to rule out the possi-
bility that transcytosing molecules were transported past a
potential point of diversion before vacuoles were fully
formed. Therefore, we pretreated cells for 120 min with
wortmannin before antibody labeling of live cells. As
shown in Fig. 6, transcytosis remained fully functional. We
observed no further impairment of 5
 
9
 
NT delivery to the
apical surface and no increased intracellular staining rela-
tive to cells pretreated for only 15 min. Importantly, we
also determined the steady state distributions of APN in
the same cells to determine if transcytosing 5
 
9
 
NT mole-
cules appeared in vacuoles. Comparison of the staining
patterns in Fig. 6, a and b, and c and d,
 
 
 
reveals that the
structures containing trafficking 5
 
9
 
NT were distinct from
vacuoles. Some 5
 
9
 
NT molecules were found in discrete
structures surrounding the APN-positive vacuoles, but the
patterns never overlapped.
These results revealed that basolateral-to-apical trans-
cytosing molecules in wortmannin-treated cells did not
accumulate in vacuoles, but seemed to traverse similar
membrane compartments (albeit displaced or delayed) as
in control cells. Therefore, we turned to ultrastructural
analysis of antibody-antigen complexes in wortmannin-
treated cells to further examine the compartments through
which the molecules were traveling. In particular, we were
interested in determining whether 5
 
9
 
NT traveled through
the SAC, a known intermediate of the transcytotic path-
way in hepatocytes (Barr and Hubbard, 1993; Barr et al.,
1995; Ihrke et al., 1998). As shown in Fig. 5, gold-conju-
gated anti–5
 
9
 
NT antibodies were detected at the apical
Figure 5. Transcytosing apical plasma membrane proteins bypass
vacuoles. (a–f) Cells were pretreated for 15 min in the absence or
presence of 100 nM wortmannin (wtm) at 378C. The cells were
chilled to 48C and labeled with anti–59NT antibodies for 15 min.
After extensive washing, the cells were either fixed and perme-
abilized directly (0 min of chase; a and d) or placed at 378C and
the antibodies chased for 90 (b and e) or 180 (c and f) min in the
continued absence or presence of 100 nM wortmannin. After
chase, the cells were fixed, permeabilized, and the trafficked anti-
bodies detected with cy3-conjugated secondary antibodies. The
control experiment is shown in a–c and wortmannin-treated cells
are shown in d–f. Asterisks in a and d point to unlabeled bile
canalicular domains at 0 min of chase in both control and treated
cells. Bar, 10 mm. (g–k) Cells were pretreated and labeled as
described above, except anti–59NT antibodies were directly con-
jugated to 5-nm gold particles. The antibodies were chased for 90
min in the continued absence (g and h) or presence (i–k) of 100 nM
wortmannin and processed for electron microscopic visualization
(see Methods). Arrows are pointing to gold particles located at
the apical cell surface or in the SAC in both control and treated
cells. Bar, 250 nm. 
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surface in both control and treated cells after 90 min of
trafficking. As predicted, gold particles were also observed
just adjacent to the apical cell surface in the SAC. Exami-
nation of the SAC in control and treated cells revealed no
significant differences in its placement, size, or number
(Table II). These data indicate that the SAC remained
functional during treatment and further show that the in-
tracellular structures containing trafficking 5
 
9
 
NT in wort-
mannin-treated cells were not an altered SAC. The iden-
tity of the compartment containing trafficking 5
 
9NT in
treated cells is not known, but may likely be an altered
early endosomal compartment, another known intermedi-
ate of the transcytotic pathway in hepatocytes (Barr and
Hubbard, 1993; Barr et al., 1995; Ihrke et al., 1998). Pre-
liminary studies revealed that these structures stained pos-
itive for ASGP-R (data not shown). Also, when 59NT and
ASGP-R were trafficked together and visualized, both
molecules traversed a similar compartment (data not
shown), presumably an early endosome.
To directly determine whether the resident apical
plasma membrane proteins in vacuoles originated from
the apical cell surface, we examined the trafficking of anti-
gen–antibody complexes that were first delivered to the
apical surface. For this analysis, APN or 59NT molecules
were labeled at the basolateral surface at 48C, chased to
the apical membrane for several hours at 378C, chased an
additional 2 h in the presence or absence of wortmannin,
and labeled with secondary antibodies for immunofluores-
cent detection. As shown in Fig. 7, b and h, nearly all the
labeled APN or 59NT molecules were at the apical surface
in control cells. After the final 2 h chase in the presence of
wortmannin, APN and 59NT staining was observed in vac-
uoles (Fig. 7, d, f, and j). These data indicate that the apical
membrane proteins found in vacuoles originate from the
apical surface. This is the first direct evidence for internal-
ization of membrane proteins from the hepatic apical cell
surface.
Characteristics of Intracellular Accumulation of Apical 
Plasma Membrane Proteins
To further characterize the mechanism(s) by which resi-
dent apical membrane proteins were internalized and ac-
cumulated intracellularly, we examined the effect of cy-
toskeletal disruption on redistribution. Microtubules were
depolymerized by addition of 33 mM nocodazole for 1 h at
378C (as assayed by b-tubulin staining, data not shown).
The cells were further incubated for 180 min with wort-
mannin in the continued absence or presence of nocoda-
zole. As shown in Fig. 8, the addition of nocodazole pre-
vented vacuole formation, further implying that vacuolar
compartments were enlarged due to accumulated cargo
and membrane received from vesicular intermediates.
Consistent with this conclusion, microtubule disruption
Figure 6. Longer pretreatment
of cells with wortmannin does
not lead to the vacuolar accumu-
lation of transcytosing apical
plasma membrane proteins.
WIF-B cells were pretreated
with 100 nM wortmannin for 120
min at 378C, subsequently
chilled to 48C, and labeled with
anti–59NT antibodies. After ex-
tensive washing the cells were
returned to 378C and the anti-
bodies chased for 60 (a and b) or
120 (c and d) min. Anti–59NT
antibodies were detected with
cy3-conjugated secondary anti-
bodies (b and d). The corre-
sponding steady state APN dis-
tributions were determined in
the same cells (a and c). Arrows
point to vacuoles that contain
APN in a and c and the corre-
sponding areas in b and d. Note
the lack of colocalization be-
tween the steady state APN la-
beling and the trafficking 59NT
molecules. Bar, 10 mm.
Table II. Wortmannin Does Not Alter the Morphology or 
Function of the SAC
Time
Diameter of SAC containing
transcytosing 59NT
Gold positive
structures per 10 mm
apical plasma membrane
2wtm 1wtm 2wtm 1wtm
min mm mm
0— — — —
90 0.17 6 0.08 0.16 6 0.03 0.9 1.1
180 0.18 6 0.1 0.17 6 0.1 0.8 1.0
Cells were labeled with gold-conjugated anti–59NT antibodies for 15 min at 4°C. Af-
ter extensive washing, the antibodies were chased for the indicated times in the pres-
ence or absence of wortmannin. The cells were fixed, processed, and analyzed as de-
scribed in Materials and Methods. The diameters of gold-positive structures within 1
mm of the bile canalicular membrane were measured. If a structure was asymmetric in
shape, the longest axis was measured. In general, the gold-positive structures were
amorphous or cup-shaped and small (,200 nm). After 0 min of chase, no intracellu-
lar gold was identified. To calculate the number of gold-positive structures per 10-mm
length of apical plasma membrane, data from three experiments were pooled and are
presented as a single value. Measurements of organelle diameter were performed on
the same three experiments and values are expressed as the mean 6 SD. For each
condition, between 12 and 33 bile canaliculi and between 135 and 476 mm of apical
plasma membrane were examined.Tuma et al. Apical Endocytosis in Polarized Hepatocytes 1097
also prevented any detectable intracellular accumulation
of APN (Fig. 8 d). Similar experiments were performed
using 1 mM cytochalasin D to disrupt the actin cytoskeletal
network. Although actin filaments were depolymerized,
no changes in the kinetics of vacuole formation or apical
protein redistribution were observed (data not shown).
Apical Plasma Membrane Proteins also Redistribute 
into Vacuoles in Hepatocytes In Situ and MDCK Cells
Because the effects of PI 3-kinase inhibitors on protein
trafficking patterns and cellular morphology have been ex-
amined only in cultured cells, it was important to rule out
the possibility of a tissue culture–induced effect by the in-
hibitors. Therefore, we treated hepatocytes in isolated
perfused livers with 2 mM wortmannin for 180 min. We ob-
served hepatocyte vacuolation with positive staining for
APN (Fig. 9 b’) and 59NT (data not shown). As observed
for WIF-B cells, the vacuoles also contained the resident
lysosomal membrane proteins, endolyn-78 (Fig. 9 b’) and
LGP-120 (data not shown). HA321 and HA4 distributions
did not change in treated livers, indicating that similar
wortmannin-sensitive transport steps were operating in in-
tact hepatocytes as in WIF-B cells (Fig. 9, d and f). These
results indicate that regulation of apical internalization by
wortmannin-sensitive molecules occurs in the intact liver.
To determine whether vacuolar accumulation of api-
cal membrane proteins is a phenomenon specific to he-
patocytes, we examined the effects of wortmannin and
LY294002 on the distributions of membrane proteins in
MDCK cells. As shown in Fig. 10, wortmannin induced the
formation of large vacuoles that also stained positive for
the endogenous resident apical membrane protein, 3F2
(compare Fig. 10, c with d). The distribution of the baso-
lateral resident membrane protein, G12, remained un-
altered by wortmannin treatment (data not shown). The
kinetics of vacuolar formation and apical protein redistri-
bution in MDCK cells were similar to those observed in
WIF-B cells. Within 30 min, all cells contained numerous
large vacuoles (Fig. 10 e). Vacuolar 3F2 staining was ob-
served after 30 min of treatment in z50% of cells and, by
120 min, nearly all cells examined contained vacuoles pos-
itive for 3F2 (Fig. 10 e). These results indicate that PI
3-kinase is regulating the dynamics of resident plasma
membrane proteins in MDCK cells and suggest that simi-
lar processes may be operating in other polarized epithe-
lial cell types.
Discussion
Using a pharmacological approach, we have documented
for the first time the internalization of apical membrane
proteins from the canalicular surface of hepatocytes.
When the PI 3-kinase inhibitors, wortmannin and LY-
294002, were applied to WIF-B cells or intact liver hepa-
tocytes, large lysosomal vacuoles formed that con-
tained apical plasma membrane proteins. Residents of
other organelles, including the basolateral plasma mem-
brane and early or late endosomes were completely or
largely absent from these structures. The source of the api-
cal membrane proteins was the apical plasma membrane
itself.
Our study has several important implications. First, our
Figure 7. The apical proteins accumulated in vacuoles originate
from the apical cell surface. WIF-B cells were chilled to 48C and
labeled with anti–APN (a–f) or anti–59NT antibodies (g–h). Af-
ter extensive washing, the cells were returned to 378C and the an-
tibodies allowed to chase for 5 h (in the case of APN antibodies)
or 3 h (for 59NT antibodies). Cells were then incubated in the ab-
sence (a, b, g, and h) or presence (c, d, i, and j) of 100 nM wort-
mannin (wtm) for an additional 2 h. Cells were fixed, permeabi-
lized, and labeled with secondary antibodies. The corresponding
phase images are shown in the left-hand column. In b and h, no
vacuolar staining is observed in untreated cells. Arrows are
pointing to vacuoles that stained positive for apical plasma mem-
brane proteins after the additional incubation with wortmannin
in c–f and i–j. Bar, 10 mm.The Journal of Cell Biology, Volume 145, 1999 1098
finding that PI 3-kinase inhibitors affect apical endocytosis
differently from basolateral endocytosis in both MDCK
and hepatic cells adds to the list of differences between en-
docytic properties of the two plasma membrane domains
in epithelial cells. Secondly and unexpectedly, the SAC,
which we identified both in vivo and in WIF-B cells as an
intermediate in the basolateral-to-apical transcytosis of
apical proteins, is not involved in apical endocytosis. We
know this because the plasma membrane proteins found
in vacuoles did not traverse the SAC. Furthermore, PI
3-kinase inhibitors have little or no effect on SAC’s baso-
lateral-to-apical function or morphology. Thus, the results
of this study support our earlier hypothesis that apical
plasma membrane proteins present in SAC are delivered
exclusively to the apical membrane even though other
SAC cargo (i.e., endolyn-78) can be sorted off to other
destinations (Ihrke et al., 1998). Finally, since our results
show that the life cycles of selected resident apical mem-
brane proteins include delivery to lysosomes, we propose
that degradation in this organelle is the normal fate of
such membrane proteins.
Identification of the PI 3-Kinase Isoform Involved
Mammalian cells, including hepatocytes, encode at least
three different classes of PI 3-kinase isoforms (for review,
see Carpenter and Cantley, 1996; Shepherd et al., 1996;
Toker and Cantley, 1997; Vanhaesebroeck et al., 1997).
Class I includes the catalytic 110-kD subunits complexed
with other accessory proteins. Class II PI 3-kinases include
higher molecular weight kinases that contain C2 domains,
and class III kinases share the highest sequence similarity
with the sole isoform identified in yeast, Vps34p. All mam-
malian PI 3-kinase isoforms are sensitive to wortmannin
and LY294002 at the concentrations used in the studies
described here and elsewhere (Shepherd et al., 1996; Van-
haesebroeck et al., 1997; Corvera and Czech, 1998). This
has led to ambiguity in distinguishing the roles that spe-
cific PI 3-kinases play in membrane transport.
Despite the present uncertainties in a pharmacological
approach, a picture emerging from studies in multiple cell
types identifies the lysosomal system as the principal tar-
get of PI 3-kinase regulation. Yeast strains deficient in the
sole PI 3-kinase isoform, Vps34p, missort lysosomal hy-
drolases from the trans-Golgi network to the extracellular
medium (Herman and Emr, 1990; Herman et al., 1992).
Recently, a mammalian homologue of this enzyme has
been implicated in both transferrin recycling and deliv-
ery of activated PDGF receptor to lysosomes, pointing to
its role in endosomal sorting/retrieval (Siddhanta et al.,
1998). However, others have reported that a p110p85 iso-
form (Class I), traditionally viewed as a mediator of signal
transduction (Carpenter and Cantley, 1996; Toker et al.,
1997; Vanhaesebroeck et al., 1997), also influences trans-
ferrin recycling and PDGF receptor delivery to lysosomes
(Siddhanta et al., 1998; Joly et al., 1994). Equally intrigu-
ing is the report that Vps34p, and by inference membrane
transport, may play a role in mitogenesis (Siddhanta et al.,
1998). Clearly, we need specific probes to dissect these
complex and interacting pathways.
Our understanding of how PI 3-kinases regulate vesicle
trafficking in mammalian cells is also in its infancy. Several
proteins with roles in membrane transport have been
shown to bind PI 3-kinase catalytic products (phosphati-
dylinositol 3 phosphate (PtdIns(3)P), PtdIns(3,4)P2, and
PtdIns(3,4,5)P3) in vitro including dynamin, the clathrin
adaptor protein, AP2, GRP1, cytohesin-1, EEA1 and
ARNO (De Camilli et al., 1996; Klarlund et al., 1997; Patki
et al., 1997; Corvera and Czech, 1998). One possibility is
that the inhibition of the formation of specific lipid species
by wortmannin in turn inhibits the recruitment of these
factors to cellular membranes where they function in
membrane transport. In hepatocytes, the roles these pro-
teins play (if any) in apical membrane internalization have
not been identified. Alternatively, the lipids themselves
may contribute to alterations in membrane physical prop-
erties that allow membrane transport to occur (e.g., fluid-
ity, fusibility). Further experimentation is clearly needed
to discriminate between these possibilities.
Apical and Basolateral Endocytosis Differ in Yet 
Another Way
Our finding that PI 3-kinase inhibitors differentially affect
the behaviors of apical and basolateral membrane proteins
in both WIF-B and MDCK cells is consistent with other
pharmacological studies of endocytosis in polarized epi-
thelial cells. For example, in MDCK cells, addition of
calmodulin antagonists (W7 and trifluoperazine) or phor-
bol esters activated apical endocytosis of ricin, while no
changes were seen at the basolateral domain (Llorente et
al., 1996; Shurety et al., 1996). In Caco2 and MDCK cells,
addition of cytochalasin D inhibited apical uptake of fluid
phase markers and no changes were observed from the ba-
solateral domain (Gottlieb et al., 1993; Jackman et al.,
1994; Shurety et al., 1996). These differences, as well as
Figure 8. Vacuolar formation and apical redistribution are mi-
crotubule-dependent processes. WIF-B cells were treated for 60
min in the absence (a and b) or presence (c and d) of 33 mM no-
codazole (nz) to depolymerize microtubules. Cells were then in-
cubated with 100 nM wortmannin (wtm) in the continued ab-
sence (a and b) or presence (c and d) of nocodazole. Cells were
fixed, permeabilized, and processed for indirect immu-
nofluorescent detection of APN steady state distributions. The
corresponding phase images are shown. Arrows in a and b point
to vacuoles that are positive for APN staining. In c and d, vacuole
formation and redistribution of APN are inhibited by nocodazole
treatment. Bar, 10 mm.Tuma et al. Apical Endocytosis in Polarized Hepatocytes 1099
Figure 9. Apical plasma mem-
brane proteins redistribute to lyso-
somally derived vacuoles in intact
liver hepatocytes. Intact livers were
perfused in the absence or presence
of 2 mM wortmannin (wtm) and 50
mM leupeptin for 180 min at 378C.
Biopsies were removed and fixed
by immersion. Semi-thin sections
(0.5  mm) were cut and processed for
indirect immunofluorescence. Con-
trol perfused liver sections (a–a”)
and wortmannin-perfused sections
(b–b”) are shown. APN staining is
shown (a’ and b’) with correspond-
ing double-labeled images for en-
dolyn (a” and b”). Phase images for
both conditions are shown at the
top of each column. HA4 (c) and
HA321 (f) staining patterns are
shown as single labels with corre-
sponding phase images. Arrows in
a–a” and b–b” point to vacuoles
that are visible by phase and are
positive for both APN and endolyn
staining. Arrows in c and e point to
vacuoles with no detectable HA4
or HA321 staining. The image
showing APN staining in treated
hepatocytes (b’) was overexposed
to enhance vacuolar staining visu-
alization. Bar, 10 mm.The Journal of Cell Biology, Volume 145, 1999 1100
those observed with PI 3-kinase inhibitors, may reflect the
specialized functions and/or environments of each mem-
brane domain.
Differential effects of wortmannin administration were
also seen among apical plasma membrane proteins. APN
and 59NT (as reported here) and dipeptidyl peptidase IV
and polymeric IgA receptor (Tuma, P.L., data not shown)
all accumulated in lysosomal vacuoles in treated cells,
whereas HA4 and syntaxin 3 maintained their apical dis-
tributions. No overt sequence or structural motifs are ap-
parent that group the proteins in the two classes, nor are
the half-lives of the proteins significantly different. Differ-
ences have been determined in the kinetics of delivery of
newly synthesized proteins to the apical surface (Bartles
et al., 1987; Schell et al., 1992). In particular, HA4 was
found to be the slowest molecule with only 15–20% de-
tected at the apical membrane after 2.5 h. Whether slower
delivery also implies slower rates of internalization from
the apical membrane and, by extension, decreased vacu-
olar accumulation, is not known. Further examination of
these molecules in terms of lipid binding properties and
specific internalization mechanisms (e.g., vesicle types, sig-
nals) are required before we understand the reasons for
the selective regulation by PI 3-kinases.
Although wortmannin and LY294002 have been shown
to impair transcytosis of dIgA and ricin in MDCK cells
(Cardone and Mostov, 1995; Hansen et al., 1995), the ef-
fect of these agents on cellular morphology or the distribu-
tions of apical membrane proteins had not been examined
before this report. Thus, our finding that MDCK cells mir-
ror WIF-B cells in the regulation by PI 3-kinases leads us
to predict that many of the apical regulatory mechanisms
described for other polarized epithelial cells may be oper-
ating at the hepatocyte canalicular domain.
Apical Plasma Membrane Proteins Are Degraded
in Lysosomes
Based on the results of this study, we propose that apical
membrane proteins are degraded in lysosomes as part of
their normal life cycle. While such a fate might have been
expected, this study is the first to document accumulation
of resident apical membrane proteins in a lysosomal com-
partment of polarized hepatic cells. These results are con-
sistent with limited examples from polarized intestinal
cells (Caco-2; Matter et al., 1990). Our proposal raises sev-
eral questions. For example, why are the levels of apical
proteins in the vacuoles so low? From fluorescent micro-
graphs, we estimate that ,5% of the apical proteins are
found there after 120 min treatment with wortmannin. The
subtlety of the effect is probably not due to degradation of
a portion of the population since addition of lysosomal
proteinase inhibitors, such as leupeptin, together with
longer exposure of cells to wortmannin, did not signifi-
cantly increase the signal. Rather, we favor an explanation
that takes into account the apical proteins’ relatively long
half-lives, which are between 3 and 6 d in vivo (Scott and
Hubbard, 1992). That is, if such long-lived molecules re-
main at the apical membrane until they are retrieved for
degradation, only 1–3% of the total APN or dipeptidyl
peptidase IV would be sorted to lysosomes in 120 min, a
value consistent with our estimations. Despite the good
agreement, we cannot rule out the formal possibility that
wortmannin induced endocytosis at the apical domain. In-
terestingly, this model assumes that the apical proteins do
not recycle through an intracellular compartment(s) as
part of their normal life cycle. Alternatively, the recycling
compartment is not sensitive to wortmannin.
Another question raised by our results is why there is
any expression of apical proteins if the vacuoles are degra-
dative. The ability to detect apical proteins in the vacuoles
suggests that they have decreased degradative potential,
consistent with their identification in other cells as prely-
sosomal intermediates. In treated WIF-B cells, cathepsin
D (an acid hydrolase) staining was not observed in vacu-
oles, but in smaller, punctate structures, implying that ma-
ture lysosomes are not altered by wortmannin (Tuma,
P.L., data not shown). Reports from NRK and human
Figure 10. Apical plasma membrane proteins in MDCK cells ac-
cumulate in vacuoles in the presence of wortmannin. (a–d)
MDCK cells were treated in the absence (a and b) or presence (c
and d) of 2 mM wortmannin and 50 mM leupeptin for 120 min at
378C. Cells were fixed, permeabilized, and processed for indirect
immunofluorescent detection of the apical plasma membrane
protein, 3F2 (b and d). The corresponding phase images are
shown (a and c). The nuclear focal plane is shown in a and the
cell surface focal plane is shown in b. Arrows point to vacuoles
that contain 3F2 in wortmannin-treated cells. Bar, 10 mm. (e)
Vacuole formation and appearance of positive 3F2 vacuole stain-
ing was measured as described in Fig. 2. The average of two ex-
periments is plotted for each time point.Tuma et al. Apical Endocytosis in Polarized Hepatocytes 1101
melanoma (Mel JuSo) cells have documented that dense
core (and presumably end-stage) lysosomes were not
changed by wortmannin with regard to their morphology
(Brown et al., 1995; Reaves et al., 1996; Spiro et al., 1996;
Fernandez-Borja et al., 1999) or their ability to receive in-
ternalized proteins and lipid dyes (Reaves et al., 1996;
Shpetner et al., 1996; Fernandez-Borja et al., 1999). In ad-
dition, previous studies have shown that acid hydrolases
are missorted to the constitutive secretory pathway in
wortmannin-treated cells (Brown et al., 1995; Davidson,
1995; Martys et al., 1996). Thus, similar missorting may oc-
cur in hepatic cells such that the vacuoles have decreased
hydrolytic activity.
A final puzzle focuses on the vacuoles themselves. If en-
try of apical membrane into this prelysosomal compart-
ment continues but subsequent events are blocked by PI
3-kinase inhibition, resulting in an enlarged vacuole, what
is the “normal” mechanism for maintaining the steady
state dimensions of the compartment in untreated cells? A
tempting hypothesis is that membrane microdomains in-
vaginate into the luminal space and pinch off to form mul-
tivesicular endosomes/lysosomes. This scenario would ac-
complish both degradation of membrane components and
maintenance of compartment size. However, there is lim-
ited experimental evidence for such an idea (Haigler et al.,
1979; van Deurs et al., 1993; Futter et al., 1996).
SAC Is Not an Intermediate in the Delivery of Resident 
Apical Proteins to Lysosomes
Our recent studies of plasma membrane biogenesis have
focused on the “indirect” route taken by newly synthe-
sized apical membrane proteins and identified SAC as a
subapical compartment in that route (Barr and Hubbard,
1993; Barr et al., 1995; Ihrke et al., 1998). It is important
to emphasize that transcytosing apical proteins moved
through the SAC and were successfully delivered to the
apical surface in wortmannin-treated cells. Ultrastructural
analysis confirmed these results and further revealed that
the morphology, placement, and number of the subapical
organelles were not changed by wortmannin. Thus, the
function of the SAC as an intermediate in the transcytotic
pathway was not changed. Most importantly, in the pres-
ence of wortmannin, the resident apical proteins did not
travel through the SAC on their way to lysosomal vacu-
oles. This indicates that the SAC is not an intermediate of
the apical endocytic pathway and is consistent with work
in hepatocytes that biochemically identified the SAC and
found it contained no recycling resident populations of
apical membrane proteins (Barr and Hubbard, 1993; Barr
et al., 1995). Previously, we proposed that the SAC is a
“one-way” sorting station to the apical domain and the re-
sults presented here continue to support our hypothesis.
What is the entry point for those apical membrane resi-
dents that were subsequently found in the lysosomal vacu-
oles? Endosomal structures have been identified in other
polarized cells that receive proteins internalized from the
apical surface (Bomsel et al., 1989; Hughson and Hopkins,
1990; Apodaca et al., 1994; Barroso and Sztul, 1994). Mor-
phologically, these compartments resemble the SAC in he-
patic cells (Parton et al., 1989; Apodaca et al., 1994; Knight
et al., 1995; Odorizzi et al., 1996). Since we are limited in
our ability to access the apical surface, we have been un-
able to directly test whether the hepatic SAC acts simi-
larly. However, there are recent reports of a subapically
located structure in HepG2 cells receiving fluorescently la-
beled glycosphingolipids (C6-NBD-glucosylceramide and
C6-NBD-sphingomyelin) that have been first accumulated
at the apical surface (van IJzendoorn et al., 1997; van
IJzendoorn and Hoekstra, 1998). Whether this compart-
ment is identical to the SAC or if it receives apically in-
ternalized proteins is not currently known. Future ex-
periments are needed to distinguish among the various
possibilities and to identify the putative intracellular com-
partment that receives incoming cargo from the apical
membrane.
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